Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Rocket Pharmaceuticals, Inc. (RCKT) had Return on Investments of -53.61% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-258.75M |
|
-- |
|
-- |
|
$273.20M |
|
$-273.20M |
|
$14.46M |
|
$-258.75M |
|
$-258.75M |
|
$-258.75M |
|
$-258.75M |
|
$-258.75M |
|
$-258.75M |
|
$-273.20M |
|
$-263.83M |
|
94.81M |
|
94.81M |
|
$-2.73 |
|
$-2.73 |
|
| Balance Sheet Financials | |
$378.18M |
|
$36.79M |
|
$149.52M |
|
$527.70M |
|
$40.68M |
|
$19.38M |
|
$23.78M |
|
$64.47M |
|
$463.23M |
|
$398.93M |
|
$463.23M |
|
106.45M |
|
| Cash Flow Statement Financials | |
$-209.72M |
|
$131.71M |
|
$185.74M |
|
$57.28M |
|
$165.00M |
|
$107.72M |
|
$43.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.30 |
|
-- |
|
-- |
|
0.04 |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-215.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-55.86% |
|
-64.86% |
|
-49.03% |
|
|
Return on Investments |
-53.61% |
$4.35 |
|
$-2.27 |
|
$-2.21 |
|